Matches in Wikidata for { <http://www.wikidata.org/entity/Q74827663> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- Q74827663 description "artículu científicu espublizáu en xunetu de 1998" @default.
- Q74827663 description "im Juli 1998 veröffentlichter wissenschaftlicher Artikel" @default.
- Q74827663 description "scientific article published on 01 July 1998" @default.
- Q74827663 description "wetenschappelijk artikel" @default.
- Q74827663 description "наукова стаття, опублікована в липні 1998" @default.
- Q74827663 name "Efaroxan, an alpha-2 antagonist, in the treatment of progressive supranuclear palsy" @default.
- Q74827663 name "Efaroxan, an alpha-2 antagonist, in the treatment of progressive supranuclear palsy" @default.
- Q74827663 type Item @default.
- Q74827663 label "Efaroxan, an alpha-2 antagonist, in the treatment of progressive supranuclear palsy" @default.
- Q74827663 label "Efaroxan, an alpha-2 antagonist, in the treatment of progressive supranuclear palsy" @default.
- Q74827663 prefLabel "Efaroxan, an alpha-2 antagonist, in the treatment of progressive supranuclear palsy" @default.
- Q74827663 prefLabel "Efaroxan, an alpha-2 antagonist, in the treatment of progressive supranuclear palsy" @default.
- Q74827663 P1433 Q74827663-445FFAE8-0717-4409-AD3D-A0BC750CD5FE @default.
- Q74827663 P1476 Q74827663-3F4C929D-F795-4BA3-A8CA-7CE5DB1BBD27 @default.
- Q74827663 P2093 Q74827663-319EA302-487A-430D-92E1-CDB43EB0A7B5 @default.
- Q74827663 P2093 Q74827663-37F0B17D-1050-42F6-AEF4-5710C6A83154 @default.
- Q74827663 P2093 Q74827663-4244644B-E24A-4BC9-AA8E-751F243D9124 @default.
- Q74827663 P2093 Q74827663-72A1EDE8-98EF-434F-BAC4-54FEF49B245A @default.
- Q74827663 P2093 Q74827663-7C1FF27C-4727-4660-A7BA-5EB2CC074B41 @default.
- Q74827663 P2093 Q74827663-9D0308E5-B9C7-473F-A28C-F5387AC31F10 @default.
- Q74827663 P2093 Q74827663-B677A63B-6C18-44D6-A3D8-556CFA764114 @default.
- Q74827663 P2093 Q74827663-BB7F70AE-441A-4A9A-897B-438C61ED712A @default.
- Q74827663 P304 Q74827663-6A892C95-44E8-4691-B625-3CE8CA914490 @default.
- Q74827663 P31 Q74827663-04FB0F68-E15C-474D-8F00-F41499BD75A9 @default.
- Q74827663 P356 Q74827663-65AE51F1-43BA-4618-9E27-B58D47D7C5EE @default.
- Q74827663 P433 Q74827663-701F311F-E9CF-48A1-9205-F0BD5E68938E @default.
- Q74827663 P478 Q74827663-8827511F-3914-4178-AA6E-4C66A3E2BE70 @default.
- Q74827663 P50 Q74827663-6DA2B01C-FB51-4E0D-BA02-1A48C8205B73 @default.
- Q74827663 P577 Q74827663-0E4FEBE7-1445-4135-BFDF-A19244C0A345 @default.
- Q74827663 P698 Q74827663-51351B84-A39F-4DF1-B4C6-748695C0A97A @default.
- Q74827663 P921 Q74827663-0F2C7602-5A21-432E-876D-D63EDB368ABA @default.
- Q74827663 P356 MDS.870130411 @default.
- Q74827663 P698 9686773 @default.
- Q74827663 P1433 Q1486418 @default.
- Q74827663 P1476 "Efaroxan, an alpha-2 antagonist, in the treatment of progressive supranuclear palsy" @default.
- Q74827663 P2093 "Brefel-Courbon C" @default.
- Q74827663 P2093 "Ladure P" @default.
- Q74827663 P2093 "Lees A" @default.
- Q74827663 P2093 "Montastruc JL" @default.
- Q74827663 P2093 "Peyro-Saint-Paul H" @default.
- Q74827663 P2093 "Rascol O" @default.
- Q74827663 P2093 "Sieradzan K" @default.
- Q74827663 P2093 "Thalamas C" @default.
- Q74827663 P304 "673-676" @default.
- Q74827663 P31 Q13442814 @default.
- Q74827663 P356 "10.1002/MDS.870130411" @default.
- Q74827663 P433 "4" @default.
- Q74827663 P478 "13" @default.
- Q74827663 P50 Q59707505 @default.
- Q74827663 P577 "1998-07-01T00:00:00Z" @default.
- Q74827663 P698 "9686773" @default.
- Q74827663 P921 Q945930 @default.